Dr. Ronald T Oye, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 730 Spaans Dr, Ste A, Galt, CA 95632 Phone: 209-745-2880 Fax: 209-745-6840 |
Dr. David Q Le, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1061 C St Ste 140, Galt, CA 95632 Phone: 209-730-7477 Fax: 209-334-6557 |
Kimberlee Itsuko Sakai, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 730 Spaans Dr Ste A, Galt, CA 95632 Phone: 209-745-2880 Fax: 209-745-6840 |
News Archive
Blue Cross Blue Shield of Massachusetts (BCBSMA), a locally-based, community-focused health plan, announced its new community partner strategy at a reception earlier this month. To support the Commonwealth, the company will focus on four key areas: healthy child development, education enrichment, healthy environments and family nutrition, and sustainable health care.
Advaxis, Inc. (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) vaccine company, in collaboration with its scientific founder and Scientific Advisory Board Chair Dr. Yvonne Paterson, have shown that epitope spreading occurs in response to a form of the Company's proprietary technology that targets tumor blood vessels (anti angiogenic antigen).
Researchers at The Wistar Institute announce the release of an online tool that will help scientists find "gene promoters"—regions along a DNA strand that tell a cell's transcription machinery where to start reading in order to create a particular protein.
In a special series called "AIDS: A Turning Point," NPR reports on global progress against HIV/AIDS ahead of the AIDS 2012 conference taking place in Washington, D.C., this month. As part of the series, NPR's "Morning Edition" examines Botswana's response to the epidemic, writing, "A decade ago, Botswana was facing a national crisis as AIDS appeared on the verge of decimating the country's adult population.
Following a recent judgment of the European Court of Justice in the 'Novartis' case (Case 106/01), the MHRA has decided to change its policy concerning the assessment of generic equivalents of line extension products.
› Verified 4 days ago